清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

#2934 SGLT2 inhibitors awaken the norns: unraveling novel erythropoietic mechanisms in diabetic nephropathy

医学 糖尿病肾病 蛋白尿 血红蛋白 内科学 糖尿病 肾活检 泌尿科 肾 肾脏疾病 肾病 内分泌学 队列 胃肠病学 肾小管病变 活检 血压 队列研究 肾病科 红细胞 疾病 病理 终末期肾病 蛋白尿 观察研究 2型糖尿病 促红细胞生成素 发病机制 红细胞生成 细胞 肾功能 药理学
作者
Davide Viggiano,Ilenia Gravina,Michelangelo Nigro,Pierluigi D’Angiò,Marco Guarneri,Carlo Giammaresi,C. Zummo,Laura Alioto,Simona Laurino,Giuseppe Gigliotti,Angelo Ferrantelli
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:40 (Supplement_3)
标识
DOI:10.1093/ndt/gfaf116.0534
摘要

Abstract Background and Aims Interstitial fibroblast-like cells that produce erythropoietin, recently identified as "Norn cells," significantly advance our understanding of renal physiology. Our study examines how sodium-glucose cotransporter-2 inhibitors (SGLT2i) influence erythropoiesis in patients with diabetic nephropathy. While SGLT2 inhibitors are established nephroprotective agents, their ability to increase hemoglobin levels remains an underappreciated effect that warrants further investigation. This hemoglobin-raising effect starkly contrasts other nephroprotective agents, particularly renin-angiotensin-aldosterone system inhibitors (RAASi), which typically reduce hemoglobin levels. Specifically, we analyze changes in hemoglobin levels and explore the mechanistic interactions between SGLT2 inhibition and these specialized interstitial cells in diabetic kidney disease. We aim to elucidate the currently unclear mechanisms underlying this unique therapeutic effect. Method In this retrospective, three-center observational study, we analyzed 371 patients with chronic kidney disease (CKD). The cohort had a mean age of 65 years and consisted predominantly of male (65%) and Caucasian (98%) individuals. Clinical and laboratory parameters were evaluated at baseline and following 7 months of treatment with SGLT2 inhibitors. Additionally, we performed histological analysis of renal biopsies from 15 SGLT2i-treated patients and 15 matched controls who had not received gliflozins. The control group was matched for age, eGFR, proteinuria and blood pressure to ensure comparable baseline characteristics. Results Hemoglobin levels showed a statistically significant median increase of 0.40 g/dL (P-value 2.63 x 10⁻¹¹). Renal biopsy analysis revealed a significant reduction in proximal tubular cell thickness and interstitial cell number, with no changes in endothelial cell count or capillary cross-sectional area. Notably, interstitial cell count correlated with creatinine levels. The observed hemoglobin increase suggests potential interactions with Norn cells, including reduced tubular metabolic stress and restored erythropoietin production. Conclusion The study reveals the multifaceted effects of SGLT2 inhibitors on erythropoiesis in patients with chronic kidney disease. Beyond their established glycosuric and nephroprotective properties, these agents can improve hemoglobin levels through mechanisms independent of traditional erythropoietic pathways. Our findings suggest that SGLT2 inhibition may modulate tubular function and potentially enhance the activity of erythropoietin-producing Norn cells in the renal interstitium. However, the precise molecular mechanisms require further investigation. This beneficial effect on hemoglobin levels is particularly noteworthy as it contrasts with the anemic tendencies often observed with other nephroprotective medications. These observations expand our understanding of SGLT2 inhibitors' pleiotropic effects and suggest new therapeutic possibilities for managing the complex interplay between chronic kidney disease and hematological dysfunction. The ability to simultaneously address renal protection and anemia represents a significant advancement in CKD management, potentially reducing the need for exogenous erythropoiesis-stimulating agents in some patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
果哥发布了新的文献求助10
7秒前
王世卉完成签到,获得积分10
19秒前
果哥完成签到,获得积分10
24秒前
美满的幻竹完成签到,获得积分10
26秒前
2797924221完成签到,获得积分10
38秒前
43秒前
成就雁玉完成签到,获得积分10
43秒前
orixero的应助被科研通管家采纳,获得10
57秒前
斯文尔珍完成签到,获得积分10
1分钟前
大胆的夜白完成签到,获得积分10
1分钟前
1分钟前
Julian完成签到,获得积分0
1分钟前
包容大地完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
雅风发布了新的文献求助10
1分钟前
着急的靖柔完成签到,获得积分10
1分钟前
1分钟前
靓丽凌珍完成签到,获得积分10
2分钟前
心灵美懿轩完成签到,获得积分10
2分钟前
小秦大qq完成签到 ,获得积分10
2分钟前
呆萌的曼易完成签到,获得积分10
2分钟前
2分钟前
阳光手机完成签到,获得积分10
2分钟前
2分钟前
雪山飞龙完成签到,获得积分10
2分钟前
无私的碧玉完成签到,获得积分10
2分钟前
shoemaker完成签到,获得积分10
3分钟前
3分钟前
369ninja发布了新的文献求助30
3分钟前
3分钟前
RRui完成签到,获得积分10
3分钟前
zachary009完成签到 ,获得积分10
3分钟前
zhang完成签到 ,获得积分10
3分钟前
111完成签到 ,获得积分10
3分钟前
Hj完成签到 ,获得积分10
3分钟前
3分钟前
危机的曼卉完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179980
求助须知:如何正确求助?哪些是违规求助? 9570196
关于积分的说明 21808504
捐赠科研通 7775913
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557383
邀请新用户注册赠送积分活动 2478998